ArticleActa pharmacologica Sinica2024

Britannin as a novel NLRP3 inhibitor, suppresses inflammasome activation in macrophages and alleviates NLRP3-related diseases in mice.

Jing-Jing Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.